Grant: Engage Grants Program
University of British Columbia
$25,000.00
Development of encapsulation materials and design for implantable 3D bioprinted pancreatic cells
EF 2019-20
Résumé
Emerging cellular therapies have the potential to both greatly improve the health of individuals and to reduce healthcare costs with improved treatments for injuries or curing diseases. For example, it has been established that a cellular transplant therapy can reverse and potentially cure type 1 diabetes. However, the development of reliable and economical means of mammalian cell manufacturing and delivery of these therapies is essential to ensure that many promising emerging health care technologies become widely available to the patients who need them. Thus, the great promise of these emerging treatments comes with great challenges, many of those in the field of cell culture process and device engineering that this project addresses. Ultimately, increased access to safe and affordable cell culture products will improve the quality of many thousands of Canadian lives. UBC and Canadian multidisciplinary groups are among the leaders in this area of research. Exporting these technologies and knowledge should benefit populations around the world as well as translate into substantial commercial benefits for Canadians.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
543791-2019
Name nom
Piret, James
Department département
Michael Smith Laboratories
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Development of encapsulation materials and design for implantable 3D bioprinted pancreatic cells
Keyword
NSERC
Application summary
Emerging cellular therapies have the potential to both greatly improve the health of individuals and to reduce healthcare costs with improved treatments for injuries or curing diseases. For example, it has been established that a cellular transplant therapy can reverse and potentially cure type 1 diabetes. However, the development of reliable and economical means of mammalian cell manufacturing and delivery of these therapies is essential to ensure that many promising emerging health care technologies become widely available to the patients who need them. Thus, the great promise of these emerging treatments comes with great challenges, many of those in the field of cell culture process and device engineering that this project addresses. Ultimately, increased access to safe and affordable cell culture products will improve the quality of many thousands of Canadian lives. UBC and Canadian multidisciplinary groups are among the leaders in this area of research. Exporting these technologies and knowledge should benefit populations around the world as well as translate into substantial commercial benefits for Canadians.